Print this page

Consolidated Balance Sheet 

XLS

 

 

 

€ million

March 31, 2012

Dec. 31, 2011

Current assets

 

 

Cash and cash equivalents

1,086.8

937.8

Marketable securities and financial assets

755.2

1,117.1

Trade accounts receivable

2,343.5

2,328.3

Inventories

1,658.9

1,691.1

Other current assets

250.6

250.2

Tax receivables

67.8

72.7

 

6,162.8

6,397.2

Non-current assets

 

 

Intangible assets

11,466.7

11,764.3

Property, plant and equipment

3,020.9

3,113.4

Non-current financial assets

63.9

60.3

Other non-current assets

70.9

54.9

Deferred tax assets

705.1

730.0

 

15,327.4

15,722.9

 

 

 

Total assets

21,490.2

22,120.1

 

 

 

Current liabilities

 

 

Current financial liabilities

797.5

1,394.4

Trade accounts payable

1,112.8

1,100.8

Other current liabilities

1,101.7

1,102.1

Tax liabilities

364.2

399.4

Current provisions

360.0

365.5

 

3,736.2

4,362.2

Non-current liabilities

 

 

Non-current financial liabilities

4,061.9

4,144.9

Other non-current liabilities

16.5

43.6

Non-current provisions

623.4

619.5

Provisions for pensions and other post-employment benefits

1,143.6

1,136.9

Deferred tax liabilities

1,270.7

1,319.6

 

7,116.2

7,264.5

Net equity

 

 

Equity capital

565.2

565.2

Reserves

8,776.5

8,671.7

Gains/losses recognized immediately in equity

1,248.5

1,210.2

Equity attributable to Merck KGaA shareholders

10,590.2

10,447.1

Non-controlling interest

47.6

46.3

 

10,637.8

10,493.4

 

 

 

Total liabilities and stockholders’ equity

21,490.2

22,120.1

© Merck KGaA, Darmstadt, Germany, Last Update 2012/05/15